Search

everythinglearnresearchcommunity

for

Search:↓

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Early hormones shape sex-specific differences in rat glands.

miR-200a reduces goose fibroblast growth by targeting PITX2 in the Wnt pathway.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Hair can darken after inflammation and then return to its original color.

BECD helps straighten wavy hair by reducing undulation.

Chronic hair diseases can severely impact mental health and self-confidence.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Transplanting skin cells is a safe, effective, and affordable treatment for vitiligo.

Special cells can help regrow hair in alopecia areata.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Enhancing Tregs can protect against alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Genetically modified cells improved skin wound healing in rats.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

RCS-01 cell therapy is safe and improves skin gene expression.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

UV light helped human hair transplants survive in mice without broad immunosuppression.